American Tower Is A Buy - Cramer's Lightning Round (6/17/16)

|
Includes: AMT, BGS, EW, FRO, GWPH, LTC, NAT, NVCR, PATK, VTR, XOM
by: SA Editor Mohit Manghnani

Summary

GW Pharmaceuticals is a speculative play.

Edwards Lifesciences has long-term upsides.

Ventas is a better stock than LTR Properties.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday, June 17.

Bullish Calls

GW Pharmaceuticals (NASDAQ:GWPH): It's a speculative stock and Cramer believes that medical marijuana needs to be standardized.

NovoCure (NASDAQ:NVCR): They have a good CEO and their stock does not deserve to be down.

Edwards Lifesciences Corp. (NYSE:EW): The stock went down on Brexit woes. It has a great future and investors should be in it.

American Tower Corp. (NYSE:AMT): This is the go-to company for telecoms who want to add more towers.

Patrick Industries (NASDAQ:PATK): It's a play on housing and lower interest rates.

Bearish Calls

B&G Foods (NYSE:BGS): It has run up to $45 which makes it difficult to recommend at these levels.

LTC Properties (NYSE:LTC): Ventas (NYSE:VTR) is a better pick.

Frontline (NYSE:FRO): "No, we are passing on Frontline. We feel really good about the Nordic American Tanker (NYSE:NAT) deal with Exxon (NYSE:XOM)."

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.